Clinicopathological features of Epstein-Barr virus-associated nasal T/NK cell lymphomas in southern Japan

Auris Nasus Larynx

Volumn 28, Issue 1, 2001, Pages 61-70

  Seki, Daihachiro ^a   Ueno, Kazuyoshi ^b   Kurono, Yuichi ^a   Eizuru, Yoshito ^c  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b Department of Otolaryngology   (Japan)

^c KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Epstein Barr virus; Epstein Barr virus encoded RNA 1 in situ hybridization; Immunohistochemistry; Latent membrane protein 1 gene; Nasal T natural killer cell lymphoma

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; GENE PRODUCT; LATENT MEMBRANE PROTEIN 1; LEUKOSIALIN; VIRUS RNA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DNA SEQUENCE; EPSTEIN BARR VIRUS; FEMALE; GENE DELETION; GENETIC VARIABILITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION; JAPAN; MALE; NATURAL KILLER CELL; NOSE CARCINOMA; PREVALENCE; PROGNOSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; T CELL LYMPHOMA; VIRUS GENE; VIRUS INFECTION;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; GENE DELETION; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KILLER CELLS, NATURAL; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; RNA, VIRAL; VIRAL MATRIX PROTEINS;

EID: 0035200711     PISSN: 03858146     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0385-8146(00)00069-9     Document Type: Article

References (39)

1. Epstein-Barr virus in nasal T-cell lymphoma in patients with lethal midline granuloma
2. Frequency of Epstein-Barr viral DNA in 'Western' 'sinonasal and Waldeyer's ring non-Hodgkin's lymphomas
3. CD56 (NKH-1)-positive hematolymphoid malignancies: An aggressive neoplasm featuring frequent cutaneus/mucosal involvement, cytoplasmic azurophilic granules, and angiocentricity
4. Report of the workshop on nasal and related extranodal angiocentric T/natural killer cell lymphomas: Definitions, differential diagnosis, and epidemiology
5. Classification of natural killer (NK) cell and NK-like T-cell malignancies
6. Polymorphic reticulosis and conventional lymphomas of the nose and upper aerodigestive tract: A clinicopathologic study of 70 cases, and immunophenotypic studies of 16 cases
7. Peripheral T cell lymphoma presenting primarily as lethal midline granuloma
8. Nation-wide study of lethal mid-line granuloma in Japan: Frequencies of Wegener's granulomatosis, polymorphic reticulosis, malignant lymphoma and other related conditions
9. Epstein-Barr virus in Malaysian upper-aerodigestive-tract lymphoma: Incidence and subtype
10. Presence of Epstein-Barr virus DNA in nasal lymphomas of B and T cell type
11. Molecular epidemiology of Epstein-Barr virus (EBV) in EBV-related malignancies
12. Nasal T-cell lymphoma: A clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus
13. Presence of Epstein-Barr virus in extranodal T-cell lymphomas: Differences in relation to site
14. Association of Epstein-Barr virus with polymorphic reticulosis
15. Association of the subtype 2 of the Epstein-Barr virus with T-cell non-Hodgkin's lymphoma of the midline granuloma type
16. Expression of natural killer cell markers in non-Hodgkin's lymphomas
17. Lethal midline granuloma with a novel T-cell phenotype as found in peripheral T-cell lymphoma
18. Nasal T/Natural Killer (NK)-cell lymphomas are derived from Epstein-Barr virus-infected cytotoxic lymphocytes of both NK- and T-cell lineage
19. +
20. Nonnasal lymphoma expressing the natural killer cell marker CD56: A clinicopathological study of 49 cases of an uncommon aggresive neoplasm
21. + cells neoplastic or reactive?
22. Expression of adult and fetal natural killer cell markers in sinonasal lymphomas
23. Frequent expression of CD3 (in CD3 (Leu4)-negative nasal T-cell lymphomas
24. Polymorphic reticulosis: A reappraisal
25. Nasal T-cell lymphoma causally associated with Epstein-Barr virus: Clinicopathologic, phenotypic, and genotypic studies
26. Isolation and sequencing of Epstein-Barr virus BNLF-1 gene (LMP-1) from a Chinese nasopharyngeal carcinoma
27. Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from nasopharyngeal carcinoma in the Taiwanese population
28. Deletions and single-base mutaions within the carboxy-terminal region of the latent membrane protein 1 oncogene in Epstein-Barr virus-related gastric cancers of southern Japan
29. Molecular analysis of LMP (latent membrane protein) oncogene in Hodgkin's disease
30. Nasal lymphomas in Peru: High incidence of T-cell immunophenotype and Epstein-Barr infection
31. Detection of Epstein-Barr viral RNA in malignant lymphomas of upper aerodigestive tract
32. In-situ localization of Epstein-Barr virus encoded RNA in non-nasal/nasopharyngeal CD56-positive and CD56-negative T-cell lymphomas
33. Expression of cytoplasmic CD3ε proteins in activated human adult natural killer (NK) cells and CD3γ, δ, ε complexes in fetal NK cells
34. Frequent expression of CD3ε in CD3 (Leu4)-negative nasal T-cell lymphomas
35. Isolation of cDNA clones encoding the 20 K T3 glycoprotein of human T-cell receptor complex
36. A conformational epitope expressed upon association of CD3ε with either CD3-δ or CD3-γ is the main target for recognition by anti-CD3 monoclonal antibodies
37. + peripheral blood lymphocytes
38. + T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas
39. Neural cell adhesion molecule-positive peripheral T-cell lymphoma: A rare variant with a propensity for unusal sites of involvement